Endogenous inhibitors of the Na,K pump

Mineral and Electrolyte Metabolism

Volumn 22, Issue 5-6, 1996, Pages 303-310

  Doris, Peter A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

ascorbic acid; digitalis glycosides; hypertension; Na,K ATPase; natriuresis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; BUFOGENIN; CARDIAC GLYCOSIDE; OUABAIN;

ENZYME ACTIVITY; HUMAN; KIDNEY; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASCORBIC ACID; ENZYME INHIBITORS; HUMANS; HYPERTENSION; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; SODIUM;

DIGITALIS; STROPHANTHUS GRATUS;

EID: 0029825229     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Chen KK, Jenssen H: A pharmacognostic study of Ch'an Su, the dried venom of the Chinese toad. J Am Pharm Assoc 1929;18:244-251.
2. Withering W: An account of the foxglove and some of its medical uses. Birmingham, 1785.
3. Greef K, Schadewaldt H: Introduction and remarks on the history of cardiac glycosides; in Greef K (ed): Cardiac Glycosides. I. Experimental Pharmacology. New York, Springer, 1981, pp 1-12.
4. Glynn IM: All hands to the sodium pump. J Physiol (Lond) 1993;462:1-30.
5. Stein WD: The sodium pump in the evolution of animal cells. Philos Trans R Soc Lond [B] 1995;249:263-269.
6. Canfield VA, Xu KY, D'Aquila T, Shyjan AW, Levenson R: Molecular cloning and characterization of Na,K-ATPase from Hydra vulgaris: Impliccations for enzyme evolution and ouabain sensitivity. New Biol 1992;4:339-348.
7. Sun DY, Guo JZ, Hartmann HA, Uno H, Hokin LE: Differential expression of the alpha2 and beta messenger RNAs of Na,K-ATPase in developing brine shrimp as measured by in situ hybridization. J Histochem Cytochem 1992;40:555-562.
8. Baxter-Lowe LA, Guo JZ, Bergstrom EE; Hokin LE: Molecular cloning if the Na,K-ATPase alpha-subunit in developing brine shrimp and sequence comparison with higher organisms. FEBS Lett 1989;257:181-187.
9. Holzinger F, Frick C, Wink M: Molecular basis for the insensitivity of the monarch (Danaus plexippus) to cardiac glycosides. FEBS Lett 1992;314:477-480.
10. Woolfson RG, Poston L, Dewardener HE: Digoxin-like inhibitors of active sodium transport and blood pressure: The current status. Kidney Int 1994;46:297-309.
11. Haddy FJ, Buckalew VM: Endogenous digitalis-like factors in hypertension; in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, ed 2, New York, Raven Press, 1995, vol 1 + 2, pp 1055-1067.
12. Hamlyn JM, Manunta P: Ouabain, digitalis-like factors and hypertension. J Hypertens 1992;10:S99-S111.
13. Hamlyn JM, Ludens JH: Non-atrial natriuretic hormones; in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. New York, Raven Press, 1992, pp 1885-1924.
14. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T: Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992;44:377-399.
15. Doris PA: Endogenous regulation of sodium pump activity. Endocrinol Metab Clin North Am 1993;7:241-260.
16. Doris PA: Regulation of Na,K-ATPase by endogenous ouabain-like materials. Proc Soc Exp Biol Med 1994;205:202-212.
17. Munzer JS, Daly SE, Jewell-Motz EA, Lingrel JB, Blostein R: Tissue- and isoform-specific kinetic behavior of the Na,K-ATPase. J Biol Chem 1994;269:16668-16676.
18. De Wardener HE, Mills IH, Clapham WF, Hayter CJ: Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961;21:249-258.
19. Kramer HJ, Gonick HC, Paul WL, Lu E: Third factor: inhibitor of Na,K-ATPase? Proc 4th International Congress of Nephrology, Stockholm 1969, pp 1-373.
20. Buckalew VMJ, Martinez FJ, Green WE: The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest 1970;49:926-935.
21. Clough DL, Pamnani MB, Overbeck HW, Haddy FJ: Decreased myocardial Na,K-ATPase in rats with one-kidney, Goldblatt hypertension. Fed Proc 1977;36:491.
22. Clough DL, Pamnani MB, Haddy FJ: Decreased myocardial Na,K-ATPase in one-kidney, one-clip hypertensive rats. Am J Physiol 1983;245:H244-H251.
23. Haddy FJ, Overbeck HW: The role of humoral agents in volume-expanded hypertension. Life Sci 1976;19:935-948.
24. Overbeck HW, Pamnani MB, Akera T, Brody TM, Haddy FJ: Depressed function of a ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ Res 1976;38(suppl II):48-52.
25. Pamnani MB, Huot S, Buggy J, Clough D, Haddy FJ: Demonstration of a humoral inhibitor of the Na-K pump in some models of experimental hypertension. Hypertension 1981; 3(suppl II):96-101.
26. Delfert DM, Valdes R: Impact of digoxin-like immunoreactive factors on digoxin measurements by immunoassays. J Clin Immunoassay 1985;8:157-164.
27. Pudek MR, Seccombe DW, Jacobson BE, Whitfield MF: Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Clin Chem 1983;29:1972-1974.
28. Gruber KA, Whitaker JM, Buckalew VM: Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980;287:743-745.
29. Blaustein MP, Hamlyn JM: Role of a natriuretic factor in essential hypertension: A hypothesis. Ann Intern Med 1983;98:785-792.
30. 2+ stores and cell responsiveness. Am J Physiol 1993;264:C1367-C1387.
31. Chayen R, Mezur Y, Wyler H, Berman E, Potgieter E, Goldberg S: Urodienolone from grapefruit juice, a urinary metabolite found in hypertensive subjects. Phytochemistry 1988;27:369-372.
32. Goad LJ, Goodwin TW: The biosynthesis of sterols in higher plants. Biochem J 1966;99: 735-737.
33. Goad LJ, Goodwin TW: Studies on phytosterol biosynthesis: The sterols of larix decidua leaves. Eur J Biochem 1967;1:357-358.
34. Sagnella GA, MacGregor GA: Characteristics of Na,K-ATPase inhibitors in extracts of tea. Am J Clin Nutr 1984;40:46-49.
35. Tamura M, Harris TM, Phillips D, Blair IA, Wang YF, Hellerqvist CG, Lam SK, Inagami T: Identification of two cardiac glycosides as Na-pump inhibitors in rat urine and diet. J Biol Chem 1994;269:11972-11979.
36. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, DuCharme DW: Development of an immunoassay for endogenous digitalis-like factor. Hypertension 1991;17: 936-943.
37. Ludens JH, Clark MA, DuCharme DW, Lutzke BS, Mandel F, Mathews WR, Sutter DM, Hamlyn JM: Purification of an endogenous digitalis-like factor from human plasma for structural analysis. Hypertension 1991;17: 923-929.
38. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, Ludens JH: Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 1991;17:930-935.
39. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH: Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991;88: 6259-6263.
40. Boulanger BR, Lilly MP, Hamlyn JM, Laredo J, Shurtleff D, Gann DS: Ouabain is secreted by the adrenal gland in awake dogs. Am J Physiol 1993;264:E413-E419.
41. Laredo J, Hamilton BP, Hamlyn JM: Secretion of endogenous ouabain from bovine adrenocortical cells: Role of the zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun 1995;212:487-493.
42. Laredo J, Hamilton BP, Hamlyn JM: Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994;135:794-797.
43. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, Lo L-C, Berova N, Nakanishi K, Haber E, Haupert GT: Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA 1993;90:8189-8193.
44. Zhao N, Lo LC, Berova N, Nakanishi K, Tymiak AA, Ludens JH, Haupert GT: Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: Nanogram scale CD structural analysis. Biochemistry 1995;34:9893-9896.
45. Kitano S, Morimoto S, Koh E, Ogihara T: The adrenals release accumulated exogenous ouabain at volume expansion in reduced renal mass hypertensive rats. Hypertension 1993;22: 432.
46. Kitano S, Morimoto S, Fukuo K, Ogihara T: The adrenals accumulate endogenous ouabain and may be the origin of plasma ouabain in rats. Hypertension 1992;20:404.
47. Anner BM, Haupert GT: Use of two-sided bifunctional liposomes in the study of a hypothalamic Na,K-ATPase inhibitor. J Cardiovasc Pharmacol 1993;22:S51-S53.
48. +-ATPase. Am J Physiol 1990;258:F144-F153.
49. Doris PA, Hayward-Lester A, Bourne D, Stocco DM: Ouabain production by cultured adrenal cells. Endocrinology 1996;137:533-539.
50. Cook JS, Will PC, Proctor WR, Brake ET: Turnover of ouabain-binding sites and plasma membrane proteins in HeLa cells; in Cook JS (ed): Biogenesis and Turnover of Membrane Macromolecules. New York, Raven Press, 1976, pp 15-36.
51. Will PC, Longworth JW, Brake ET, Cook JS: Analysis of intracellular drug (ouabain) sequestration as a mechanism of detoxification. Mol Pharmacol 1977;13:161-171.
52. Doris PA, Jenkins LA, Stocco DM: Is ouabain an authentic endogenous mammalian substance derived from adrenal gland? Hypertension 1994;23:632-638.
53. Gomez-Sanchez EP, Foeking MF, Sellers D, Blankenship MS, Gomez-Sanchez CE: Is the circulating ouabain-like compound ouabain? Am J Hypertens 1994;7:647-650.
54. Pidgeon GB, Lewis LK, Richards AM, Nicholls GM: Studies on ouabain: Plasma levels and pressor effects. Hypertension 1994;24:385.
55. Meyer K, Linde H: Collection of toad venoms and chemistry of toad venom steroids; in Bucherl W, Buckley E (eds): Venomous Animals and Their Venoms. New York, Academic Press, 1971, pp 1-521.
56. Siperstein MD, Murray AW, Titus E: Biosynthesis of cardiotonic sterols from cholesterol in the toad, Bufo marinus. Arch Biochem Biophys 1957;67:154.
57. Porto AM, Gros EG: Biosynthesis of the bufadienolide marinobufagin in toads Bufo paracnemis from cholesterol-20-14C. Experientia 1970;26:506.
58. Chen C, Osuch MV: Biosynthesis of bufadienolides-3-beta-hydroxycholanates as precursors in Bufo marinus bufadienolides synthesis. Biochem Pharmacol 1969;18:1797-1802.
59. Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE: Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension 1995;26:781-788.
60. Schoner W, Kirch U, Sich B, Antonolovich R: Purification and some properties of an inhibitor of the sodium pump from bovine adrenals cross-reacting with proscillaridin A antibodies. Biol Chem Hoppe Seyler 1993;374:SP-181.
61. Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, Deutsch J: Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem 1993;216:261-268.
62. Ng Y-C, Akera T, Han C-S, Braselton WE, Kennedy RH, Temma K, Brody T, Sato P: Ascorbic acid: An endogenous inhibitor of isolated Na,K-ATPase. Biochem Pharmacol 1985;34:2525-2530.
63. Kramer HJ, Krampitz G, Backer A, Michel H, Krampitz G, Meyer-Lehnert H: Endogenous sodium pump inhibitors in human urine. Am J Hypertens 1995;8:753-760.
64. Kramer HJ, Krampitz G, Backer A, Krampitz G, Meyer-Lehnert H: Vanadium diascorbates are strong candidates for endogenous ouabain-like factors in human urine: Effects on Na,K-ATPase enzyme kinetics. Biochem Biophys Res Commun 1995;213:289-294.
65. Doris PA: Digoxin-like immunoreactive factor in rat plasma: Effect of sodium and calcium intake. Life Sci 1988;42:783-790.
66. Doris PA: Immunological evidence that the adrenal gland is the source of an endogenous digitalis-like factor in the rat. Endocrinology 1988;123:2440-2444.
67. Doris PA, Stocco DM: An endogenous digitalis-like factor derived from the adrenal gland: Studies of adrenal tissue from various sources. Endocrinology 1989;125:2573-2579.
68. Doris PA, Kilgore MW, Durham D, Stocco DM: An endogenous digitalis-like factor derived from the adrenal gland: Studies of adrenocortical tumor cells. Endocrinology 1989; 125:2580-2586.
69. Doris PA: Characterization and Scatchard binding analysis of adrenal digitalis-like material. Life Sci 1992;50:1935-1941.
70. Schreiber V, Stepan J, Gregorova I, Krejcikova J: Crossed digoxin immunoreactivity in chromatography fractions of rat adrenal extract. Biochem Pharmacol 1981;30:805-806.
71. Tamura M, Lam T-T, Inagami T: Isolation and characterization of a specific endogenous Na,K-ATPase inhibitor from bovine adrenal. Biochemistry 1988;27:4244-4253.
72. Tamura M, Naruse M, Sakakibara M, Inagami T: Isolation of an endogenous Na-pump specific inhibitor from normal pig urine - Characterization and comparison with the inhibitor purified from bovine adrenal glands. Biochim Biophys Acta 1993;1157:15-22.
73. Rasheed N, Doris PA: Production of cardiac glycoside-like material by Y1 cells in serum-free conditions. FASEB J 1995;9:A637.